Evidence map›Paper›PMID 15328154›Full record

ArticleBlood2005

NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Jeyarani Regunathan, Yuhong Chen, Demin Wang, Subramaniam Malarkannan

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Cancer immunology research · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeyarani RegunathanBlood Research Institute, Blood Center of Southeastern Wisconsin, Milwaukee 53226, USA.
Yuhong Chen
Demin Wang
Subramaniam Malarkannan
Medical College of Wisconsin · US

Funding

Molecular Mechanisms of Natural Killer Cell ActivationR01AI064828 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI MALARKANNAN, SUBRAMANIAM · 2006 to 2010
$1.7M
NIAID NIH HHS R01 AI064828
6 · The paper itself

Abstract

Interaction of the activating ligand H60 with NKG2D receptor constitutes a major stimulatory pathway for natural killer (NK) cells. The influence of inhibitory Ly49 receptors on NKG2D-mediated activation is not clearly understood. Here we show that the magnitude of NKG2D-mediated cytotoxicity is directly proportional to both the levels of H60 and the nature of major histocompatibility complex (MHC) class I molecules expressed on the target cells. The expression levels of H60 on the target cells determined the extent to which the inhibition by Ly49C/I receptors can be overridden. In contrast, even a higher expression of H60 molecule on the target cells failed to overcome the inhibition mediated by Ly49A/G receptors. Also, the level of interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GM-CSF) generated by NK cells through anti-NKG2D monoclonal antibody (mAb)-mediated activation is significantly reduced by the presence of immobilized anti-Ly49A/G mAbs. Thus, NKG2D-mediated cytotoxicity and cytokine secretion results from the fine balance between activating and inhibitory receptors, thereby defining the NK cell-mediated immune responses.

Indexed as

Active Transport, Cell NucleusAnimalsAntibodies, MonoclonalAntigens, LyCell NucleusCells, CulturedCytotoxicity, ImmunologicDown-RegulationH-2 AntigensHistocompatibility Antigen H-2DHumansKiller Cells, NaturalLectins, C-TypeLigandsMiceMinor Histocompatibility AntigensAntibodies, MonoclonalAntigens, LyH-2 AntigensHistocompatibility Antigen H-2DKlra1 protein, mouseKlra3 protein, mouseKLRK1 protein, humanKlrk1 protein, mouseLectins, C-TypeLigandsminor H antigen H60Minor Histocompatibility AntigensNF-kappa BNK Cell Lectin-Like Receptor Subfamily ANK Cell Lectin-Like Receptor Subfamily KReceptors, ImmunologicReceptors, Natural Killer CellReceptors, NK Cell Lectin-Like

Identifiers

PMID15328154
PMCPMC3889208
OpenAlexW2043586257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.